Search - tctmd.com

Displaying 681 - 700 of 881

Sort: Relevancy | Date

Presentation

Betrixaban vs. Warfarin in A-fib Patients: Results of a Phase 2, Randomized, Dose-Ranging Study

Presenter: Stuart J. Connolly

March 28, 2013

News Daily News

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

March 28, 2013

News Daily News

‘Nuisance’ Bleeding After AMI Common, Affects QoL

Yael L. Maxwell

March 28, 2013

News Daily News

SCAAR Cumple 20 Años: PCI Ampliada a Pacientes de Mayor Rieso sin Compensación de Mortalidad

March 25, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

Yael L. Maxwell

March 09, 2013

News Daily News

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Yael L. Maxwell

March 09, 2013

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

News Daily News

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

Caitlin E. Cox

March 03, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

Presentation

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

Presenter: 147572|Oluseun Alli

February 27, 2013

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

News Daily News

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Jason Kahn

February 11, 2013

Presentation

A-fib and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing TAVR

Presenter: S. Stortecky

February 10, 2013

News Daily News

SYNTHESIS Expanded: Endovascular Treatment No Better Than IV tPA for Acute Stroke

February 07, 2013

News Daily News

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

February 04, 2013

Presentation

Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular A-fib

Presenter: Manesh R. Patel

February 03, 2013

Presentation TCT 2013

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene, Philippe Genereux, Michael Ezekowitz, Ajay Kirtane, Roxana Mehran, Gregg Stone

January 31, 2013

Advertisement

Betrixaban vs. Warfarin in A-fib Patients: Results of a Phase 2, Randomized, Dose-Ranging Study

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

‘Nuisance’ Bleeding After AMI Common, Affects QoL

SCAAR Cumple 20 Años: PCI Ampliada a Pacientes de Mayor Rieso sin Compensación de Mortalidad

Remote Postconditioning Reduces AKI in NSTEMI Patients

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Quality-of-Life Assessment in the Randomized PROTECT AF Trial of Patients at Risk for Stroke with Nonvalvular A-fib

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

A-fib and Aortic Stenosis: Impact on Clinical Outcomes Among Patients Undergoing TAVR

SYNTHESIS Expanded: Endovascular Treatment No Better Than IV tPA for Acute Stroke

ROCKET AF Analysis Looks at Stroke Risk After Stopping Anticoagulation

Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular A-fib

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content